Note: BPC-157 promotes angiogenesis (new blood vessel growth). While this is beneficial for healing, it may theoretically facilitate the growth or spread of existing tumors.
Note: While often used to support gut health, patients with active flares should consult their specialist before beginning new protocols.
Note: BPC-157 is strictly prohibited at all times by the World Anti-Doping Agency (Category S0) and most athletic governing bodies.
Note: The FDA has noted potential risks of immunogenicity (immune system reactions) associated with BPC-157.
Note: The safety of BPC-157 has not been established for pregnant or nursing mothers.
Note: Because NAD+ supports cellular repair and energy, its use in active cancer is a subject of ongoing clinical debate regarding the fueling of rapidly dividing cancer cells.
Note: NAD+ metabolism involves pathways that can occasionally influence uric acid levels in sensitive individuals.
Note: Growth hormone secretagogues may accelerate the growth of existing tumors or increase the risk of recurrence.
Note: These peptides can increase blood sugar and decrease insulin sensitivity.
Note: Increased growth hormone can lead to fluid shifts that may aggravate these conditions.
Note: High copper intake can further deplete zinc levels.
Note: Both BPC-157 and TB-500 promote angiogenesis (new blood vessel growth). While this helps heal injuries, it could theoretically stimulate the growth or spread of existing tumors.
Note: Both BPC-157 and TB-500 are strictly prohibited at all times by the World Anti-Doping Agency (Category S0).
Note: The safety of these peptides has not been established for pregnant or nursing mothers.
Note: The FDA has noted potential risks of immunogenicity (immune system reactions) with compounded BPC-157.
Note: Because BPC-157, TB-500, and GHK-Cu promote angiogenesis (the formation of new blood vessels) and cellular migration, they could theoretically facilitate the growth or spread of existing tumors.
Note: The angiogenic properties of these peptides may aggravate conditions characterized by abnormal blood vessel proliferation.
Note: There is a potential risk of immunogenicity (immune system reactions) associated with certain compounded peptides.
Note: The safety profile of these peptides has not been established for pregnant or nursing mothers.
Note: BPC-157 and TB-500 are strictly prohibited at all times by the World Anti-Doping Agency (Category S0).
Note: Methionine, a primary ingredient in MIC, contains sulfur.
Note: High doses of certain nutrients can occasionally trigger these conditions in predisposed individuals.

Please review and agree to the following before proceeding:

Terms | Privacy | Waiver

© 2026 Active Medical Solutions

All Rights Reserved

1032 E Brandon Blvd #2126Brandon, FL 33511

Note: BPC-157 promotes angiogenesis (new blood vessel growth). While this is beneficial for healing, it may theoretically facilitate the growth or spread of existing tumors.
Note: While often used to support gut health, patients with active flares should consult their specialist before beginning new protocols.
Note: BPC-157 is strictly prohibited at all times by the World Anti-Doping Agency (Category S0) and most athletic governing bodies.
Note: The FDA has noted potential risks of immunogenicity (immune system reactions) associated with BPC-157.
Note: The safety of BPC-157 has not been established for pregnant or nursing mothers.
Note: Because NAD+ supports cellular repair and energy, its use in active cancer is a subject of ongoing clinical debate regarding the fueling of rapidly dividing cancer cells.
Note: NAD+ metabolism involves pathways that can occasionally influence uric acid levels in sensitive individuals.
Note: Growth hormone secretagogues may accelerate the growth of existing tumors or increase the risk of recurrence.
Note: These peptides can increase blood sugar and decrease insulin sensitivity.
Note: Increased growth hormone can lead to fluid shifts that may aggravate these conditions.
Note: High copper intake can further deplete zinc levels.
Note: Both BPC-157 and TB-500 promote angiogenesis (new blood vessel growth). While this helps heal injuries, it could theoretically stimulate the growth or spread of existing tumors.
Note: Both BPC-157 and TB-500 are strictly prohibited at all times by the World Anti-Doping Agency (Category S0).
Note: The safety of these peptides has not been established for pregnant or nursing mothers.
Note: The FDA has noted potential risks of immunogenicity (immune system reactions) with compounded BPC-157.
Note: Because BPC-157, TB-500, and GHK-Cu promote angiogenesis (the formation of new blood vessels) and cellular migration, they could theoretically facilitate the growth or spread of existing tumors.
Note: The angiogenic properties of these peptides may aggravate conditions characterized by abnormal blood vessel proliferation.
Note: There is a potential risk of immunogenicity (immune system reactions) associated with certain compounded peptides.
Note: The safety profile of these peptides has not been established for pregnant or nursing mothers.
Note: BPC-157 and TB-500 are strictly prohibited at all times by the World Anti-Doping Agency (Category S0).
Note: Methionine, a primary ingredient in MIC, contains sulfur.
Note: High doses of certain nutrients can occasionally trigger these conditions in predisposed individuals.

Please review and agree to the following before proceeding:

Terms | Privacy | Waiver

© 2026 Active Medical Solutions

All Rights Reserved

1032 E Brandon Blvd #2126Brandon, FL 33511